PHRMAG chooses new executive committee, 2 women join
DUBAI, February 15, 2021 The Pharmaceutical Research & Manufacturers in the Gulf (PHRMAG) conducted its annual General Assembly meeting and announced its new executive committee for the 2021-2023 term. In line with its commitment to promoting a more diverse and inclusive environment across the innovative biopharmaceutical industry, the new executive committee will include two female leaders - Gizem Akalin, Vice President and General Manager, GSK Gulf, and Lindsey Dietschi, Country Manager and Cluster Lead for Pfizer Gulf. Mohammad Aboubakr, General Manager, Gulf Countries, AbbVie, also joins the Executive Committee for the first time. The General Assembly also welcomed its new member Servier, raising the membership to 25 globally leading healthcare companies operating in the Gulf region.
It looks like this was the result of either:
A mistyped address
A broken link on our site
A broken link on a search engine results page
A broken link on someone else s page
Some things to try:
Use the navigation menu at the top Most Read
SAR – Badanie Producentów 2021 rozpoczęte! brief.pl - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from brief.pl Daily Mail and Mail on Sunday newspapers.
Wednesday, December 23, 2020
In addition to the incredible work of agency scientists and reviewers to get the first COVID-19 vaccines authorized for emergency use in December (as we covered in Part 2 of our year-end post), the Food and Drug Administration (FDA) has continued to make substantial progress on its non-COVID priorities as well.
Continued Progress on Non-COVID Priorities…
Besides the obvious scientific, technical, and regulatory work that FDA and other stakeholders have been doing all year to mount a comprehensive response to the emergence of SARS-CoV-2 as a pandemic pathogen, the agency’s work on other high-priority human drug and biological product regulatory programs continued during 2020. FDA has demonstrated a fairly impressive ability to manage a huge number of competing priorities, even as certain areas like pre-approval inspections and re-inspections of facilities seeking removal from an import alert have suffered in the face of travel restrict